Parexel and n-Lorem Foundation partner to support development of new investigational therapies for nano-rare patients Read more
Microbiome-targeting treatment is set to evolve, address multiple immunological indications: GlobalData Read more
CSIR-CDRI, Lucknow sign license deal with Marc Labs to develop drug for treating heart attack, stroke Read more